BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37962440)

  • 21. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus.
    Zhang Y; Chen R; Gao Y; Qu J; Wang Z; Zhao M; Bai X; Jin H
    Environ Pollut; 2023 Jan; 317():120833. PubMed ID: 36493933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
    Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gestational Perfluoroalkyl Substance Exposure and DNA Methylation at Birth and 12 Years of Age: A Longitudinal Epigenome-Wide Association Study.
    Liu Y; Eliot MN; Papandonatos GD; Kelsey KT; Fore R; Langevin S; Buckley J; Chen A; Lanphear BP; Cecil KM; Yolton K; Hivert MF; Sagiv SK; Baccarelli AA; Oken E; Braun JM
    Environ Health Perspect; 2022 Mar; 130(3):37005. PubMed ID: 35266797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Early Pregnancy Perfluoroalkyl and Polyfluoroalkyl Substance Exposure With Birth Outcomes.
    Zhang Y; Mustieles V; Sun Q; Coull B; McElrath T; Rifas-Shiman SL; Martin L; Sun Y; Wang YX; Oken E; Cardenas A; Messerlian C
    JAMA Netw Open; 2023 May; 6(5):e2314934. PubMed ID: 37256622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies.
    Forns J; Verner MA; Iszatt N; Nowack N; Bach CC; Vrijheid M; Costa O; Andiarena A; Sovcikova E; Høyer BB; Wittsiepe J; Lopez-Espinosa MJ; Ibarluzea J; Hertz-Picciotto I; Toft G; Stigum H; Guxens M; Liew Z; Eggesbø M
    Environ Health Perspect; 2020 May; 128(5):57002. PubMed ID: 32378965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational exposure to perfluoroalkyl substances and congenital heart defects: A nested case-control pilot study.
    Ou Y; Zeng X; Lin S; Bloom MS; Han F; Xiao X; Wang H; Matala R; Li X; Qu Y; Nie Z; Dong G; Liu X
    Environ Int; 2021 Sep; 154():106567. PubMed ID: 33882431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal Exposure to Perfluoroalkyl Substances and Child Behavior at Age 12: A PELAGIE Mother-Child Cohort Study.
    Tillaut H; Monfort C; Rouget F; Pelé F; Lainé F; Gaudreau E; Cordier S; Warembourg C; Saint-Amour D; Chevrier C
    Environ Health Perspect; 2023 Nov; 131(11):117009. PubMed ID: 37971539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfluoroalkyl substances exposure in early pregnancy and preterm birth in singleton pregnancies: a prospective cohort study.
    Huo X; Zhang L; Huang R; Feng L; Wang W; Zhang J;
    Environ Health; 2020 Jun; 19(1):60. PubMed ID: 32493312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
    Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
    Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment.
    Spratlen MJ; Perera FP; Lederman SA; Rauh VA; Robinson M; Kannan K; Trasande L; Herbstman J
    Environ Pollut; 2020 Aug; 263(Pt B):114444. PubMed ID: 32272335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro.
    Behr AC; Lichtenstein D; Braeuning A; Lampen A; Buhrke T
    Toxicol Lett; 2018 Jul; 291():51-60. PubMed ID: 29601859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of Exposure to Perfluoroalkyl Substances With Thyroid Hormone Concentrations and Birth Size.
    Xiao C; Grandjean P; Valvi D; Nielsen F; Jensen TK; Weihe P; Oulhote Y
    J Clin Endocrinol Metab; 2020 Mar; 105(3):735-45. PubMed ID: 31665456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No association between maternal and child PFAS concentrations and repeated measures of ADHD symptoms at age 2½ and 5 years in children from the Odense Child Cohort.
    Dalsager L; Jensen TK; Nielsen F; Grandjean P; Bilenberg N; Andersen HR
    Neurotoxicol Teratol; 2021; 88():107031. PubMed ID: 34563660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.